Drug Type Small molecule drug |
Synonyms ZED3269 |
Target |
Action inhibitors |
Mechanism TGM2 inhibitors(Protein-glutamine gamma-glutamyltransferase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetic Nephropathies | Preclinical | Germany | 03 Jul 2025 | |
| Idiopathic Pulmonary Fibrosis | Preclinical | Germany | 03 Jul 2025 | |
| Mesothelioma | Preclinical | Germany | 03 Jul 2025 |





